Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 38 | 2022 | 439 | 8.300 |
Why?
|
Alcoholism | 22 | 2023 | 346 | 6.920 |
Why?
|
Crisis Intervention | 5 | 2023 | 16 | 3.500 |
Why?
|
Primary Health Care | 20 | 2023 | 843 | 3.020 |
Why?
|
Alcohol Drinking | 12 | 2023 | 375 | 2.650 |
Why?
|
Referral and Consultation | 10 | 2022 | 178 | 2.090 |
Why?
|
Humans | 91 | 2023 | 18058 | 1.960 |
Why?
|
Telemedicine | 3 | 2022 | 187 | 1.940 |
Why?
|
Adolescent Health Services | 4 | 2021 | 43 | 1.850 |
Why?
|
Depression | 13 | 2022 | 512 | 1.670 |
Why?
|
Male | 65 | 2022 | 10173 | 1.510 |
Why?
|
Anxiety | 5 | 2020 | 153 | 1.490 |
Why?
|
Behavior, Addictive | 2 | 2022 | 12 | 1.470 |
Why?
|
Adult | 37 | 2023 | 7696 | 1.450 |
Why?
|
Mass Screening | 9 | 2022 | 678 | 1.440 |
Why?
|
Motivational Interviewing | 6 | 2022 | 32 | 1.430 |
Why?
|
Atrial Fibrillation | 7 | 2009 | 164 | 1.420 |
Why?
|
Adolescent | 38 | 2022 | 3714 | 1.400 |
Why?
|
Delivery of Health Care, Integrated | 8 | 2022 | 552 | 1.390 |
Why?
|
Coronavirus Infections | 2 | 2020 | 50 | 1.380 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 57 | 1.380 |
Why?
|
Female | 66 | 2022 | 12838 | 1.370 |
Why?
|
Mental Disorders | 10 | 2020 | 290 | 1.280 |
Why?
|
Anxiety Disorders | 3 | 2020 | 91 | 1.250 |
Why?
|
Mental Health Services | 6 | 2021 | 159 | 1.210 |
Why?
|
Substance Abuse Treatment Centers | 8 | 2016 | 75 | 1.120 |
Why?
|
Stroke | 6 | 2009 | 306 | 1.070 |
Why?
|
Hypertension | 2 | 2023 | 489 | 1.050 |
Why?
|
Cannabis | 3 | 2022 | 73 | 1.040 |
Why?
|
Health Services Accessibility | 4 | 2020 | 316 | 0.990 |
Why?
|
Pandemics | 4 | 2022 | 293 | 0.990 |
Why?
|
Comorbidity | 14 | 2021 | 618 | 0.930 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 742 | 0.930 |
Why?
|
Middle Aged | 36 | 2021 | 8073 | 0.910 |
Why?
|
Anticoagulants | 6 | 2009 | 122 | 0.890 |
Why?
|
Cardiovascular Diseases | 7 | 2019 | 613 | 0.860 |
Why?
|
Kidney Diseases | 5 | 2011 | 53 | 0.810 |
Why?
|
Aged | 26 | 2021 | 6258 | 0.810 |
Why?
|
Chronic Pain | 2 | 2020 | 125 | 0.800 |
Why?
|
Depressive Disorder | 4 | 2018 | 233 | 0.740 |
Why?
|
Delivery of Health Care | 4 | 2022 | 445 | 0.730 |
Why?
|
Anti-Anxiety Agents | 1 | 2019 | 4 | 0.720 |
Why?
|
Benzodiazepines | 1 | 2019 | 26 | 0.700 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 40 | 0.700 |
Why?
|
California | 14 | 2021 | 2327 | 0.700 |
Why?
|
Health Care Costs | 3 | 2019 | 253 | 0.680 |
Why?
|
Treatment Outcome | 18 | 2021 | 1259 | 0.670 |
Why?
|
Mental Health | 3 | 2012 | 166 | 0.670 |
Why?
|
Aging | 1 | 2020 | 159 | 0.660 |
Why?
|
Managed Care Programs | 6 | 2006 | 356 | 0.630 |
Why?
|
HIV Infections | 6 | 2021 | 682 | 0.630 |
Why?
|
Chronic Disease | 7 | 2016 | 462 | 0.620 |
Why?
|
Psychology, Clinical | 1 | 2017 | 2 | 0.620 |
Why?
|
Young Adult | 12 | 2022 | 2479 | 0.600 |
Why?
|
Child | 13 | 2022 | 2519 | 0.580 |
Why?
|
Risk Factors | 17 | 2020 | 3394 | 0.580 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 70 | 0.540 |
Why?
|
Kidney Failure, Chronic | 2 | 2016 | 148 | 0.520 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 177 | 0.520 |
Why?
|
Smoking | 5 | 2021 | 465 | 0.500 |
Why?
|
Heart Failure | 4 | 2008 | 391 | 0.500 |
Why?
|
Health Personnel | 1 | 2015 | 122 | 0.490 |
Why?
|
Practice Patterns, Physicians' | 2 | 2020 | 351 | 0.490 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 178 | 0.480 |
Why?
|
Health Status | 2 | 2016 | 331 | 0.480 |
Why?
|
Marijuana Smoking | 4 | 2018 | 49 | 0.450 |
Why?
|
Follow-Up Studies | 7 | 2021 | 1255 | 0.420 |
Why?
|
Patient Compliance | 4 | 2013 | 303 | 0.420 |
Why?
|
Hospitalization | 4 | 2019 | 813 | 0.410 |
Why?
|
United States | 13 | 2021 | 4119 | 0.410 |
Why?
|
Prevalence | 6 | 2021 | 892 | 0.400 |
Why?
|
Glomerular Filtration Rate | 6 | 2016 | 156 | 0.390 |
Why?
|
Diagnosis, Dual (Psychiatry) | 5 | 2021 | 28 | 0.390 |
Why?
|
Vitamin K | 2 | 2008 | 15 | 0.380 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 328 | 0.380 |
Why?
|
Adolescent Behavior | 4 | 2017 | 130 | 0.380 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 238 | 0.370 |
Why?
|
Continuity of Patient Care | 2 | 2021 | 113 | 0.360 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 1309 | 0.350 |
Why?
|
Warfarin | 4 | 2009 | 74 | 0.340 |
Why?
|
Aged, 80 and over | 8 | 2019 | 1956 | 0.330 |
Why?
|
Feasibility Studies | 2 | 2021 | 116 | 0.320 |
Why?
|
Patient Participation | 2 | 2022 | 143 | 0.320 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2008 | 44 | 0.320 |
Why?
|
Health Maintenance Organizations | 3 | 2006 | 481 | 0.320 |
Why?
|
Oligosaccharides | 1 | 2008 | 2 | 0.320 |
Why?
|
Sex Factors | 6 | 2021 | 634 | 0.310 |
Why?
|
Patient Acceptance of Health Care | 3 | 2018 | 397 | 0.310 |
Why?
|
Odds Ratio | 5 | 2022 | 692 | 0.310 |
Why?
|
Electronic Health Records | 3 | 2020 | 734 | 0.300 |
Why?
|
Self-Help Groups | 3 | 2013 | 32 | 0.300 |
Why?
|
Myocardial Infarction | 2 | 2011 | 251 | 0.290 |
Why?
|
Fibrinolytic Agents | 2 | 2009 | 44 | 0.280 |
Why?
|
Private Sector | 1 | 2006 | 16 | 0.280 |
Why?
|
Hemoglobins | 1 | 2006 | 38 | 0.270 |
Why?
|
Anemia | 1 | 2006 | 32 | 0.270 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2021 | 127 | 0.270 |
Why?
|
Cohort Studies | 7 | 2020 | 2631 | 0.270 |
Why?
|
Models, Organizational | 1 | 2006 | 69 | 0.270 |
Why?
|
San Francisco | 4 | 2016 | 67 | 0.260 |
Why?
|
Retrospective Studies | 4 | 2019 | 2498 | 0.250 |
Why?
|
Temperance | 3 | 2016 | 25 | 0.250 |
Why?
|
Age Factors | 4 | 2021 | 945 | 0.250 |
Why?
|
Evidence-Based Medicine | 1 | 2006 | 195 | 0.240 |
Why?
|
Cause of Death | 3 | 2016 | 181 | 0.230 |
Why?
|
Factor V | 1 | 2003 | 5 | 0.220 |
Why?
|
Alcohol-Related Disorders | 3 | 2021 | 56 | 0.220 |
Why?
|
Thromboembolism | 3 | 2009 | 33 | 0.220 |
Why?
|
Self-Injurious Behavior | 2 | 2022 | 45 | 0.220 |
Why?
|
Risk-Taking | 3 | 2016 | 113 | 0.220 |
Why?
|
Pharmacists | 1 | 2022 | 42 | 0.220 |
Why?
|
Probability | 1 | 2022 | 86 | 0.210 |
Why?
|
Pediatrics | 2 | 2015 | 164 | 0.210 |
Why?
|
Cost-Benefit Analysis | 2 | 2022 | 264 | 0.210 |
Why?
|
Pragmatic Clinical Trials as Topic | 1 | 2022 | 53 | 0.210 |
Why?
|
International Classification of Diseases | 1 | 2022 | 87 | 0.210 |
Why?
|
Machine Learning | 1 | 2022 | 41 | 0.210 |
Why?
|
Surveys and Questionnaires | 7 | 2020 | 1346 | 0.210 |
Why?
|
Risk Assessment | 4 | 2020 | 1137 | 0.200 |
Why?
|
Central Nervous System Agents | 1 | 2021 | 4 | 0.200 |
Why?
|
Outpatients | 2 | 2019 | 113 | 0.200 |
Why?
|
Angina, Stable | 1 | 2011 | 4 | 0.200 |
Why?
|
Diabetes Mellitus | 3 | 2019 | 526 | 0.200 |
Why?
|
Telephone | 1 | 2022 | 175 | 0.200 |
Why?
|
Recurrence | 2 | 2016 | 186 | 0.200 |
Why?
|
Mortality | 2 | 2016 | 121 | 0.200 |
Why?
|
Suicidal Ideation | 2 | 2022 | 102 | 0.200 |
Why?
|
Social Stigma | 1 | 2021 | 19 | 0.190 |
Why?
|
Infection Control | 1 | 2020 | 9 | 0.190 |
Why?
|
Vaping | 1 | 2021 | 17 | 0.190 |
Why?
|
Vulnerable Populations | 1 | 2020 | 45 | 0.190 |
Why?
|
Tobacco Smoking | 1 | 2021 | 18 | 0.190 |
Why?
|
Gender Identity | 1 | 2020 | 41 | 0.190 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2021 | 32 | 0.190 |
Why?
|
Workload | 1 | 2020 | 31 | 0.190 |
Why?
|
Respiratory System | 1 | 2020 | 4 | 0.190 |
Why?
|
Coronary Disease | 1 | 2011 | 182 | 0.180 |
Why?
|
Drug Prescriptions | 1 | 2021 | 157 | 0.180 |
Why?
|
Prospective Studies | 3 | 2017 | 1294 | 0.180 |
Why?
|
Activities of Daily Living | 2 | 2018 | 92 | 0.180 |
Why?
|
Health Services for the Aged | 1 | 2020 | 15 | 0.180 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 166 | 0.180 |
Why?
|
Counseling | 1 | 2022 | 199 | 0.180 |
Why?
|
Transgender Persons | 1 | 2020 | 45 | 0.180 |
Why?
|
Case-Control Studies | 5 | 2013 | 1164 | 0.180 |
Why?
|
Lorazepam | 1 | 2019 | 4 | 0.180 |
Why?
|
Interrupted Time Series Analysis | 1 | 2020 | 22 | 0.180 |
Why?
|
Pilot Projects | 1 | 2021 | 235 | 0.180 |
Why?
|
Peer Group | 3 | 2012 | 50 | 0.180 |
Why?
|
Patient Reported Outcome Measures | 1 | 2020 | 56 | 0.180 |
Why?
|
Betacoronavirus | 1 | 2020 | 36 | 0.180 |
Why?
|
Prescription Drugs | 1 | 2020 | 32 | 0.180 |
Why?
|
Self-Management | 1 | 2019 | 26 | 0.170 |
Why?
|
Health Services Needs and Demand | 2 | 2010 | 112 | 0.170 |
Why?
|
Health Resources | 1 | 2019 | 36 | 0.170 |
Why?
|
Severity of Illness Index | 3 | 2016 | 454 | 0.170 |
Why?
|
Hospital Costs | 1 | 2019 | 40 | 0.170 |
Why?
|
Text Messaging | 1 | 2019 | 30 | 0.170 |
Why?
|
Social Support | 2 | 2012 | 211 | 0.170 |
Why?
|
Risk | 4 | 2010 | 552 | 0.170 |
Why?
|
Suicide | 1 | 2020 | 126 | 0.170 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 128 | 0.160 |
Why?
|
Smoking Cessation | 1 | 2020 | 198 | 0.160 |
Why?
|
Blood Pressure | 2 | 2017 | 280 | 0.160 |
Why?
|
Data Collection | 3 | 2010 | 276 | 0.160 |
Why?
|
Longitudinal Studies | 5 | 2021 | 705 | 0.160 |
Why?
|
Medical Marijuana | 1 | 2018 | 24 | 0.160 |
Why?
|
Logistic Models | 5 | 2021 | 953 | 0.150 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 147 | 0.150 |
Why?
|
Pediatricians | 1 | 2017 | 13 | 0.150 |
Why?
|
Outcome and Process Assessment (Health Care) | 2 | 2016 | 106 | 0.150 |
Why?
|
Carbazoles | 1 | 2007 | 2 | 0.150 |
Why?
|
Tartrates | 1 | 2007 | 2 | 0.150 |
Why?
|
Propanolamines | 1 | 2007 | 3 | 0.150 |
Why?
|
Metoprolol | 1 | 2007 | 6 | 0.150 |
Why?
|
Atenolol | 1 | 2007 | 8 | 0.150 |
Why?
|
Marijuana Use | 1 | 2017 | 25 | 0.150 |
Why?
|
Marijuana Abuse | 1 | 2017 | 39 | 0.150 |
Why?
|
Patient-Centered Care | 1 | 2019 | 228 | 0.150 |
Why?
|
Family | 3 | 2012 | 119 | 0.140 |
Why?
|
Intersectoral Collaboration | 1 | 2016 | 12 | 0.140 |
Why?
|
Income | 1 | 2017 | 95 | 0.140 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 22 | 0.140 |
Why?
|
Angina Pectoris | 1 | 2006 | 16 | 0.140 |
Why?
|
Social Class | 1 | 2017 | 125 | 0.140 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 357 | 0.140 |
Why?
|
Inservice Training | 1 | 2015 | 15 | 0.140 |
Why?
|
Hemorrhage | 2 | 2008 | 63 | 0.130 |
Why?
|
Psychometrics | 4 | 2020 | 120 | 0.130 |
Why?
|
Leadership | 1 | 2015 | 42 | 0.130 |
Why?
|
Health Services | 1 | 2016 | 111 | 0.130 |
Why?
|
Patient Readmission | 1 | 2007 | 161 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 94 | 0.130 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 132 | 0.130 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2016 | 248 | 0.120 |
Why?
|
Medication Adherence | 1 | 2017 | 255 | 0.120 |
Why?
|
Physicians | 1 | 2015 | 143 | 0.120 |
Why?
|
Creatinine | 3 | 2009 | 67 | 0.120 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 667 | 0.120 |
Why?
|
Interpersonal Relations | 2 | 2012 | 41 | 0.120 |
Why?
|
Obesity | 1 | 2020 | 839 | 0.110 |
Why?
|
Incidence | 4 | 2019 | 1297 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2007 | 745 | 0.110 |
Why?
|
Emergency Medical Services | 1 | 2012 | 46 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2012 | 274 | 0.110 |
Why?
|
Case Management | 2 | 2010 | 37 | 0.110 |
Why?
|
School Health Services | 1 | 2012 | 41 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 350 | 0.100 |
Why?
|
Friends | 1 | 2012 | 10 | 0.100 |
Why?
|
Social Environment | 3 | 2012 | 93 | 0.100 |
Why?
|
Renal Dialysis | 2 | 2006 | 57 | 0.100 |
Why?
|
Disabled Persons | 1 | 2012 | 42 | 0.100 |
Why?
|
Pain | 1 | 2012 | 84 | 0.100 |
Why?
|
Health Policy | 1 | 2012 | 135 | 0.100 |
Why?
|
Reproductive Health Services | 1 | 2010 | 3 | 0.100 |
Why?
|
Patient Care | 1 | 2011 | 37 | 0.090 |
Why?
|
Reimbursement Mechanisms | 1 | 2010 | 20 | 0.090 |
Why?
|
Stress, Psychological | 1 | 2012 | 145 | 0.090 |
Why?
|
Financing, Government | 1 | 2010 | 32 | 0.090 |
Why?
|
Health Care Reform | 1 | 2010 | 33 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2010 | 89 | 0.090 |
Why?
|
Parents | 2 | 2020 | 308 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 43 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 53 | 0.090 |
Why?
|
Cooperative Behavior | 2 | 2008 | 103 | 0.090 |
Why?
|
Religion | 1 | 2009 | 14 | 0.080 |
Why?
|
Proteinuria | 1 | 2009 | 23 | 0.080 |
Why?
|
Tobacco Use Cessation | 1 | 2008 | 23 | 0.080 |
Why?
|
Prognosis | 2 | 2010 | 619 | 0.080 |
Why?
|
Research Design | 1 | 2010 | 393 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 2008 | 77 | 0.070 |
Why?
|
Self Care | 1 | 2008 | 175 | 0.070 |
Why?
|
Time Factors | 3 | 2013 | 1114 | 0.070 |
Why?
|
Systole | 1 | 2006 | 22 | 0.070 |
Why?
|
Lung Diseases | 1 | 2006 | 32 | 0.070 |
Why?
|
Organizational Case Studies | 1 | 2006 | 25 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2006 | 47 | 0.070 |
Why?
|
Universities | 1 | 2006 | 13 | 0.070 |
Why?
|
Antifibrinolytic Agents | 1 | 2005 | 3 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2005 | 16 | 0.070 |
Why?
|
Aspirin | 1 | 2005 | 67 | 0.060 |
Why?
|
Self Report | 2 | 2020 | 252 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 170 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2012 | 249 | 0.060 |
Why?
|
Family Relations | 1 | 2004 | 18 | 0.060 |
Why?
|
Molecular Epidemiology | 1 | 2003 | 44 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2003 | 37 | 0.050 |
Why?
|
Ethnic Groups | 1 | 2006 | 504 | 0.050 |
Why?
|
Patient Care Team | 1 | 2003 | 130 | 0.050 |
Why?
|
Neoplasms | 1 | 2006 | 464 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 79 | 0.050 |
Why?
|
Survival Rate | 2 | 2008 | 266 | 0.050 |
Why?
|
Nicotine | 1 | 2021 | 46 | 0.050 |
Why?
|
Wounds and Injuries | 2 | 1997 | 51 | 0.050 |
Why?
|
Time | 2 | 2010 | 20 | 0.040 |
Why?
|
Length of Stay | 2 | 2012 | 182 | 0.040 |
Why?
|
South Africa | 2 | 2010 | 17 | 0.040 |
Why?
|
Buprenorphine | 1 | 2020 | 47 | 0.040 |
Why?
|
Lipids | 1 | 2019 | 77 | 0.040 |
Why?
|
Prenatal Care | 1 | 2021 | 136 | 0.040 |
Why?
|
Demography | 2 | 2012 | 106 | 0.040 |
Why?
|
Breast Feeding | 1 | 2021 | 134 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2020 | 394 | 0.040 |
Why?
|
Community Health Services | 2 | 2010 | 85 | 0.040 |
Why?
|
Drug Overdose | 1 | 2020 | 57 | 0.040 |
Why?
|
Medicare | 1 | 2020 | 206 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2021 | 852 | 0.040 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 31 | 0.040 |
Why?
|
Aluminum | 1 | 2007 | 14 | 0.040 |
Why?
|
Morbidity | 1 | 2017 | 62 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 97 | 0.040 |
Why?
|
Wounds, Gunshot | 1 | 1997 | 14 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 118 | 0.040 |
Why?
|
Alcoholic Intoxication | 1 | 1996 | 7 | 0.040 |
Why?
|
Bicycling | 1 | 1996 | 5 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 1996 | 15 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2006 | 92 | 0.040 |
Why?
|
Suicide, Attempted | 1 | 1997 | 98 | 0.030 |
Why?
|
Regression Analysis | 2 | 2009 | 319 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2006 | 36 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2006 | 80 | 0.030 |
Why?
|
Pregnancy | 1 | 2021 | 1484 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 124 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 162 | 0.030 |
Why?
|
Survival Analysis | 1 | 2004 | 225 | 0.030 |
Why?
|
Hospitals, Voluntary | 1 | 2012 | 4 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2012 | 65 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 160 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2012 | 66 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2012 | 82 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2011 | 36 | 0.020 |
Why?
|
Body Mass Index | 1 | 2006 | 961 | 0.020 |
Why?
|
Child, Preschool | 2 | 2010 | 1428 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2010 | 97 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2012 | 595 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2010 | 123 | 0.020 |
Why?
|
Disease Progression | 1 | 2010 | 255 | 0.020 |
Why?
|
Biomarkers | 1 | 2010 | 306 | 0.020 |
Why?
|
Asthma | 1 | 2012 | 302 | 0.020 |
Why?
|
Patient Selection | 1 | 2010 | 194 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2009 | 51 | 0.020 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2008 | 20 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2008 | 33 | 0.020 |
Why?
|
Research | 1 | 2008 | 73 | 0.020 |
Why?
|
Motivation | 1 | 2008 | 133 | 0.020 |
Why?
|
Databases, Factual | 1 | 2008 | 330 | 0.020 |
Why?
|
Infant | 1 | 2010 | 1212 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2006 | 23 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2006 | 40 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2008 | 346 | 0.020 |
Why?
|
Child Rearing | 1 | 2004 | 4 | 0.020 |
Why?
|
Conflict (Psychology) | 1 | 2004 | 8 | 0.020 |
Why?
|
Conduct Disorder | 1 | 2004 | 7 | 0.020 |
Why?
|
Family Health | 1 | 2004 | 47 | 0.010 |
Why?
|
Parent-Child Relations | 1 | 2004 | 55 | 0.010 |
Why?
|
Social Work | 1 | 2003 | 14 | 0.010 |
Why?
|
Health Services Research | 1 | 2003 | 271 | 0.010 |
Why?
|
Behavior Therapy | 1 | 2003 | 152 | 0.010 |
Why?
|
Head Protective Devices | 1 | 1996 | 4 | 0.010 |
Why?
|
Maryland | 1 | 1996 | 15 | 0.010 |
Why?
|
Sex Distribution | 1 | 1997 | 192 | 0.010 |
Why?
|
Firearms | 1 | 1997 | 27 | 0.010 |
Why?
|
Ethanol | 1 | 1996 | 22 | 0.010 |
Why?
|
Age Distribution | 1 | 1997 | 257 | 0.010 |
Why?
|
Registries | 1 | 1997 | 486 | 0.010 |
Why?
|